Topic: EU-GMP

The long-term growth prospects of Vietnamese pharmaceutical companies are on the rise as they establish their position in the high-tech product segment, competing in both domestic and international markets.

The Imexpharm Pharmaceutical Joint Stock Company is committed to significantly investing in sustainable development as a strategic path to drive its future expansion into the global market.